{"id":"https://openalex.org/W2033793939","doi":"https://doi.org/10.1136/ebmh.7.2.54","title":"Office based treatment with buprenorphine plus naloxone, or buprenorphine alone reduces opiate use and craving","display_name":"Office based treatment with buprenorphine plus naloxone, or buprenorphine alone reduces opiate use and craving","publication_year":2004,"publication_date":"2004-04-23","ids":{"openalex":"https://openalex.org/W2033793939","doi":"https://doi.org/10.1136/ebmh.7.2.54","mag":"2033793939","pmid":"https://pubmed.ncbi.nlm.nih.gov/15107350"},"language":"en","primary_location":{"id":"doi:10.1136/ebmh.7.2.54","doi":"https://doi.org/10.1136/ebmh.7.2.54","is_oa":true,"landing_page_url":"https://doi.org/10.1136/ebmh.7.2.54","pdf_url":"https://mentalhealth.bmj.com/content/ebmental/7/2/54.full.pdf","source":{"id":"https://openalex.org/S160517820","display_name":"Evidence-Based Mental Health","issn_l":"1362-0347","issn":["1362-0347","1468-960X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","ki-jl-1","poland-20","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Evidence Based Mental Health","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://mentalhealth.bmj.com/content/ebmental/7/2/54.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008112632","display_name":"Linda Gowing","orcid":"https://orcid.org/0000-0002-9124-4056","observed_orcids":["https://orcid.org/0000-0002-9124-4056"]},"institutions":[{"id":"https://openalex.org/I5681781","display_name":"The University of Adelaide","ror":"https://ror.org/00892tw58","country_code":"AU","type":"education","lineage":["https://openalex.org/I4405259444","https://openalex.org/I5681781"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Linda R Gowing","raw_affiliation_strings":["Department of Clinical and Experimental Pharmacology, University of Adelaide, Adelaide, South Australia, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical and Experimental Pharmacology, University of Adelaide, Adelaide, South Australia, Australia","institution_ids":["https://openalex.org/I5681781"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5026534644","display_name":"Olga V. Lopatko","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I5681781","display_name":"The University of Adelaide","ror":"https://ror.org/00892tw58","country_code":"AU","type":"education","lineage":["https://openalex.org/I4405259444","https://openalex.org/I5681781"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Olga Lopatko","raw_affiliation_strings":["Department of Clinical and Experimental Pharmacology, University of Adelaide, Adelaide, South Australia, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical and Experimental Pharmacology, University of Adelaide, Adelaide, South Australia, Australia","institution_ids":["https://openalex.org/I5681781"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I5681781"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.22347626,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"7","issue":"2","first_page":"54","last_page":"54"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11199","display_name":"Pain Management and Opioid Use","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/buprenorphine","display_name":"buprenorphine","score":0.8859999775886536},{"id":"https://openalex.org/keywords/naloxone","display_name":"naloxone","score":0.9879999756813049},{"id":"https://openalex.org/keywords/opioid-use-disorder","display_name":"opioid use disorder","score":0.7269999980926514},{"id":"https://openalex.org/keywords/opioid-substitution-therapy","display_name":"opioid substitution therapy","score":0.8140000104904175},{"id":"https://openalex.org/keywords/office-based-treatment","display_name":"office-based treatment","score":0.8629999756813049},{"id":"https://openalex.org/keywords/sublingual-tablets","display_name":"sublingual tablets","score":0.8619999885559082},{"id":"https://openalex.org/keywords/opiate-use","display_name":"opiate use","score":0.722000002861023},{"id":"https://openalex.org/keywords/craving","display_name":"craving","score":0.7590000033378601},{"id":"https://openalex.org/keywords/treatment-effectiveness","display_name":"treatment effectiveness","score":0.37599998712539673},{"id":"https://openalex.org/keywords/drug-addiction-treatment","display_name":"drug addiction treatment","score":0.36000001430511475},{"id":"https://openalex.org/keywords/opioid-antagonists","display_name":"opioid antagonists","score":0.4169999957084656}],"concepts":[{"id":"https://openalex.org/C2778949969","wikidata":"https://www.wikidata.org/wiki/Q407721","display_name":"Buprenorphine","level":4,"score":0.8120843172073364},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7130818367004395},{"id":"https://openalex.org/C2778767360","wikidata":"https://www.wikidata.org/wiki/Q179996","display_name":"Methadone","level":2,"score":0.5843450427055359},{"id":"https://openalex.org/C2778140631","wikidata":"https://www.wikidata.org/wiki/Q2026938","display_name":"Opiate","level":3,"score":0.5235918760299683},{"id":"https://openalex.org/C2779541405","wikidata":"https://www.wikidata.org/wiki/Q498902","display_name":"Craving","level":3,"score":0.49738648533821106},{"id":"https://openalex.org/C2778750930","wikidata":"https://www.wikidata.org/wiki/Q4540629","display_name":"(+)-Naloxone","level":4,"score":0.41708019375801086},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3216189742088318},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.27864134311676025},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.2689961791038513},{"id":"https://openalex.org/C48856860","wikidata":"https://www.wikidata.org/wiki/Q12029","display_name":"Addiction","level":2,"score":0.13586336374282837},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1136/ebmh.7.2.54","doi":"https://doi.org/10.1136/ebmh.7.2.54","is_oa":true,"landing_page_url":"https://doi.org/10.1136/ebmh.7.2.54","pdf_url":"https://mentalhealth.bmj.com/content/ebmental/7/2/54.full.pdf","source":{"id":"https://openalex.org/S160517820","display_name":"Evidence-Based Mental Health","issn_l":"1362-0347","issn":["1362-0347","1468-960X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","ki-jl-1","poland-20","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Evidence Based Mental Health","raw_type":"journal-article"},{"id":"pmid:15107350","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15107350","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Evidence-based mental health","raw_type":"Comment"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.915.748","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.915.748","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://ebmh.bmj.com/content/7/2/54.full.pdf","raw_type":"text"}],"best_oa_location":{"id":"doi:10.1136/ebmh.7.2.54","doi":"https://doi.org/10.1136/ebmh.7.2.54","is_oa":true,"landing_page_url":"https://doi.org/10.1136/ebmh.7.2.54","pdf_url":"https://mentalhealth.bmj.com/content/ebmental/7/2/54.full.pdf","source":{"id":"https://openalex.org/S160517820","display_name":"Evidence-Based Mental Health","issn_l":"1362-0347","issn":["1362-0347","1468-960X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","ki-jl-1","poland-20","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Evidence Based Mental Health","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2033793939.pdf","grobid_xml":"https://content.openalex.org/works/W2033793939.grobid-xml"},"referenced_works_count":7,"referenced_works":["https://openalex.org/W2048376222","https://openalex.org/W2053314566","https://openalex.org/W2128713308","https://openalex.org/W2132974770","https://openalex.org/W2147528480","https://openalex.org/W2171498933","https://openalex.org/W2244324403"],"related_works":["https://openalex.org/W7098750424","https://openalex.org/W2147528480","https://openalex.org/W2401701863","https://openalex.org/W2068672539","https://openalex.org/W4246465577","https://openalex.org/W2901162813","https://openalex.org/W2921372217","https://openalex.org/W4292087278","https://openalex.org/W4311778528","https://openalex.org/W2178765203"],"abstract_inverted_index":{"Fudala":[0],"PJ,":[1],"Bridge":[2],"TP,":[3],"Herbert":[4],"S,":[5],"et":[6],"al":[7],".":[8],"Office-based":[9],"treatment":[10],"of":[11,18,27,121],"opiate":[12,40,94,98],"addiction":[13],"with":[14,34,93],"a":[15],"sublingual-tablet":[16],"formulation":[17],"buprenorphine":[19,33,137],"and":[20,42],"naloxone.":[21],"N":[22],"Engl":[23],"J":[24],"Med":[25],"2003;349:949\u201358.[OpenUrl][1][CrossRef][2][PubMed][3][Web":[26],"Science][4]":[28],"Q":[29],"How":[30],"effective":[31],"is":[32],"or":[35,103,116,119,125],"without":[36],"naloxone":[37],"in":[38,44,77],"reducing":[39],"use":[41,120],"craving":[43],"people":[45],"addicted":[46],"to":[47,83],"opiates?":[48],"###":[49,56,60,65,72,86,131],"![Graphic][5]":[50],"Design:":[51],"Multicentre":[52],"randomised":[53],"controlled":[54],"trial.":[55],"![Graphic][6]":[57],"Allocation:":[58],"Unclear.":[59],"![Graphic][7]":[61],"Blinding:":[62],"Double":[63],"blind.":[64],"![Graphic][8]":[66],"Follow":[67],"up":[68],"period:":[69],"Four":[70],"weeks.":[71],"![Graphic][9]":[73],"Setting:":[74],"Eight":[75],"centres":[76],"the":[78],"United":[79],"States;":[80],"October":[81],"1996":[82],"September":[84],"1997.":[85],"![Graphic][10]":[87],"Patients:":[88],"Adults":[89],"aged":[90],"18\u201359":[91],"years":[92],"dependence":[95],"(DSM-IV)":[96,111],"seeking":[97],"substitution":[99],"pharmacotherapy.":[100],"Exclusions:":[101],"pregnant":[102],"nursing":[104],"women,":[105],"primary":[106],"Axis":[107],"1":[108],"psychiatric":[109],"diagnosis":[110],"other":[112],"than":[113],"opiate,":[114],"caffeine,":[115],"nicotine":[117],"dependence,":[118],"methadone,":[122],"levomethadyl":[123],"acetate":[124],"naltrexone":[126],"14":[127],"days":[128],"before":[129],"enrolment.":[130],"![Graphic][11]":[132],"Intervention:":[133],"Sublingual":[134],"tablets":[135],"of:":[136],"(16":[138],"\u2026":[139],"[1]:":[140],"{openurl}?query=rft.jtitle%253DNew%2BEngland%2BJournal%2Bof%2BMedicine%26rft.stitle%253DNEJM%26rft.aulast%253DFudala%26rft.auinit1%253DP.%2BJ.%26rft.volume%253D349%26rft.issue%253D10%26rft.spage%253D949%26rft.epage%253D958%26rft.atitle%253DOffice-Based%2BTreatment%2Bof%2BOpiate%2BAddiction%2Bwith%2Ba%2BSublingual-Tablet%2BFormulation%2Bof%2BBuprenorphine%2Band%2BNaloxone%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJMoa022164%26rft_id%253Dinfo%253Apmid%252F12954743%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx":[141],"[2]:":[142],"/lookup/external-ref?access_num=10.1056/NEJMoa022164&link_type=DOI":[143],"[3]:":[144],"/lookup/external-ref?access_num=12954743&link_type=MED&atom=%2Febmental%2F7%2F2%2F54.atom":[145],"[4]:":[146],"/lookup/external-ref?access_num=000185081400006&link_type=ISI":[147],"[5]:":[148],"/embed/inline-graphic-1.gif":[149],"[6]:":[150],"/embed/inline-graphic-2.gif":[151],"[7]:":[152],"/embed/inline-graphic-3.gif":[153],"[8]:":[154],"/embed/inline-graphic-4.gif":[155],"[9]:":[156],"/embed/inline-graphic-5.gif":[157],"[10]:":[158],"/embed/inline-graphic-6.gif":[159],"[11]:":[160],"/embed/inline-graphic-7.gif":[161]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}